CfPIE Announces New Training Courses for Life Science Professionals

May 30, 2013
Coronavirus 2020: Everything Pharmaceutical Personnel Should Know

Expanded curriculum includes industry-recognized certification tracks offered at no additional cost


Malvern, PA - May 30, 2013 - The Center for Professional Innovation and Education (CfPIE) has introduced four new training courses for pharmaceutical, biotechnology, and medical device professionals, which include:


Clinical Trial Project Management for Phase 1 thru Phase 4: Best Practices. This Food and Drug Administration (FDA) Good Clinical Practice (GCP) course reviews all phases of clinical drug development and focuses on best practices to remain compliant with GCP guidelines and FDA regulations.


Biosimilars: Understanding Regulatory Challenges. This course examines the Chemistry, Manufacturing and Controls (CMC), nonclinical and clinical regulatory requirements from FDA, European Medicine Agency (EMA), and World Health Organization (WHO) for biosimilar biological products.


Advanced Topics for Biostatistics for Non-Statisticians. This course focuses on the statistical requirements of health science research, while addressing their effect on clinical studies.


Navigating Latin American Regulatory Compliance Requirements for Clinical Trials. This regulatory compliance course introduces the regulatory landscape in Argentina, Brazil, Chile and Peru, as well as the matrix of agency requirements that affect compliance.


The new courses provide versatile options for life science professionals to stay ahead of industry regulations, enhance cross-discipline exposure, meet professional development and certification requirements, and capitalize on personal career growth opportunities.


Each course is associated with one of CfPIE’s eleven industry-recognized certification tracks, which are offered at no additional cost above standard course fees. CfPIE’s certification program provides flexibility to choose between three core courses and one elective course to meet the diverse needs of life science professionals. All certification tracks are developed and vetted by a committee of industry experts, many whom are former FDA or international regulators.


paper_plane

Need more information on our life-science training course?

Get In Touch With Us Today!

Contact Us

Blog Categories

Operational Excellence and Sustained Procedural Discipline
November 5, 2026
Pharmaceutical workforce readiness and operational excellence are vital for product quality and safety. Learn more about preventing FDA Warning Letters.
Gap 4: What FDA Warning Letters Reveal About Data Integrity and Scientific Documentation
November 4, 2026
FDA Warning Letters show how incomplete or unreliable data can undermine investigations, batch decisions, oversight, and the pharmaceutical quality system.